Evidence map›Paper›PMID 39274926›Full record

ArticleMolecules (Basel, Switzerland)2024

Investigation on the Synergy between Membrane Permeabilizing Amphiphilic α-Hydrazido Acids and Commonly Used Antibiotics against Drug-Resistant Bacteria.

Cristina Minnelli, Gianmarco Mangiaterra, Emiliano Laudadio, Barbara Citterio, Samuele Rinaldi

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Antibacterial activity ofFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cristina MinnelliDepartment of Life and Environmental Sciences, Polytechnic University of Marche, Via Brecce Bianche, 60131 Ancona, Italy.ORCID 0000-0001-8034-8557
Gianmarco MangiaterraDepartment of Biomolecular Science, University of Urbino "Carlo Bo", 61032 Urbino, Italy.ORCID 0000-0001-5035-5879
Emiliano LaudadioDepartment of Science and Engineering of Matter, Environment and Urban Planning, Polytechnic University of Marche, Via Brecce Bianche, 60131 Ancona, Italy.ORCID 0000-0002-8053-6539
Barbara CitterioDepartment of Biomolecular Science, University of Urbino "Carlo Bo", 61032 Urbino, Italy.ORCID 0000-0003-3346-6379
Samuele RinaldiDepartment of Life and Environmental Sciences, Polytechnic University of Marche, Via Brecce Bianche, 60131 Ancona, Italy.ORCID 0000-0002-9035-1044

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The growth of (multi)drug resistance in bacteria is among the most urgent global health issues. Monocationic amphiphilic α-hydrazido acid derivatives are structurally simple mimics of antimicrobial peptides (AMPs) with fewer drawbacks. Their mechanism of membrane permeabilization at subtoxic concentrations was found to begin with an initial electrostatic attraction of isolated amphiphile molecules to the phospholipid heads, followed by a rapid insertion of the apolar portions. As the accumulation into the bilayer proceeded, the membrane increased its fluidity and permeability without being subjected to major structural damage. After having ascertained that α-hydrazido acid amphiphiles do not interact with bacterial DNA, they were subjected to synergy evaluation for combinations with conventional antibiotics. Synergy was observed for combinations with tetracycline against sensitive

Indexed as

Anti-Bacterial AgentsCell Membrane PermeabilityDrug SynergismEscherichia coliMicrobial Sensitivity TestsStaphylococcus aureusCiprofloxacinColistinDrug Resistance, BacterialDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsCiprofloxacinColistinantibiotic adjuvantsantibiotic resistancemembrane permeabilizationmolecular dynamicssynergyα-hydrazido acid derivatives

Identifiers

PMID39274926
PMCPMC11397519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.